Just a moment, the page is loading...
The Supported Studies Programme
For the latest updates on GSK’s response to COVID-19, please click here.

Our Mission Our mission

At GSK, we are dedicated to improving the quality of human life by enabling people to do more, feel better and live longer. As part of this commitment, we recognise the valuable role that Supported Studies (Investigator-Sponsored Studies (ISS) and Supported Collaborative Studies (SCS)) play in fulfilling this mission.

The Supported Studies Programme The Supported Studies Programme

Supported Studies are research conducted by an external Sponsor with GSK's support. There are two different ways GSK can provide support:

  • Investigator Sponsored Studies are entirely designed and managed by an external Sponsor. GSK can support in the form of funding and/or product (including GSK products, placebo, or other medicinal products necessary for the research). These studies are also known as Investigator-Initiated Studies, Investigator-Initiated-Trials, Investigator Initiated Research or Investigator Sponsored Research.
  • Supported Collaborative Studies are conducted by an external Sponsor, with GSK contributing to study design and deliverables, in addition to the provision of funds and/or products.

In both circumstances the Sponsor of the research is accountable for all aspects of the study as well as for complying with all applicable ethical, regulatory and legal requirements.

GSK reviews proposals received at set points throughout the year. GSK is committed to responding to your proposal within eight weeks from the closing date of the relevant submission period.

Disease Area Cycle Submission period opens Submission period close Proposal of Interest communicated First draft of protocol requested Additional Information
Consumer Health Cycle 4 01 Oct 2022 31 Dec 2022 11 Feb 2023 N/A
Consumer Health Cycle 3 01 Jul 2022 30 Sep 2022 11 Nov 2022 N/A
Consumer Health Cycle 2 01 April 2022 30 Jun 2022 11 Aug 2022 N/A
Consumer Health Cycle 1 24 Jan 2022 31 Mar 2022 12 May 2022 N/A

The below areas are of particular interest to the review committee. This was last updated in April 2022.

Oral Health
Dental plaque at the gingival margin
  • Characteristics, interaction among organisms and local immune response, consequences over defined periods of time, influencing factors.
Gingival inflammation
  • Gingivae in health and disease: quantification of extent of inflammation, markers, impact on rest of periodontium and oral health, longitudinal sequalae.
Enamel health
  • Teeth are subject to numerous challenges throughout the day from dietary sugars, acids and bacteria. Despite the use of fluoridated toothpaste and mouthwash, all these factors have contributed to a significant rise in the number of fillings, enamel wear and sensitivity. Therefore, we are seeking solutions that would protect tooth enamel from these challenges and/or repair the damage that has been caused, and/or drive further understanding of the conditions.
Dentine Hypersensitivity
  • Dentin hypersensitivity is a relatively common condition; it is one of the most commonly encountered clinical problems in dentistry. Dentine hypersensitivity is characterized by tooth pain in response to stimuli such as hot and cold food and can have a marked impact the enjoyment of daily activities and quality of life. However, the condition is manageable, and we continue to seek to develop products that help prevent the pain of dentine hypersensitivity, and explore new understandings on the condition, including impacts on quality of life, objective measures of pain and physiological parameters.
  • Epidemiological insights around toothbrushing
  • Role of toothbrushes in aetiology of dentine hypersensitivity
  • Techniques to clinically measure cervical /gingival abrasion
The burden of tooth loss
  • Implications and consequences: Function, Oral Health, Quality of Life
  • Role of dental professionals in managing change/transition for patients facing/ living with tooth loss
Care of appliances as part of daily oral hygiene routine
  • Oral hygiene needs of partially dentate patients
  • Evidence base for prevention of oral diseases in partially dentate populations
Fit and performance of removable dental appliances
  • Comfort
  • Masticatory function
  • Patients perceived needs and preferences
Pain relief

Our scientists research and develop self-treatment options to manage a range of mild to moderate pain types. The goal of our research in pain is to provide treatments and interventions that significantly improve the lives of patients living with a range of painful conditions.

We welcome research proposals especially those that evaluate:
  • The use of non-prescription pain relievers in mild to moderate pain conditions
  • Use of oral and topically applied natural products for pain
  • Combination treatments in the management of pain
Respiratory Health
  • Use of oral and topically applied non-prescription products for treatment of symptoms of cold/cough/flu:
    • Herbal/ natural ingredients for symptomatic relief of non-severe viral infections
    • QoL related studies
  • Upper respiratory tract infections
  • Allergic and non-allergic rhinitis
  • Air pollution
Skin health
  • Cold sores
  • Feet and Nail fungus infections
  • Itchy, inflamed and irritated skin
  • Skin aging
Wellness category is interested in receiving and reviewing proposals related to following research areas:
  • Naturals/ herbal ingredients
    • Riding on the Asia’s rich heritage of traditional medicines, we are interested to explore ingredients & claims in terms of immunity/ sleep, stress, anxiety/ mobility, inflammation, bone & joint health/ energy/ eye health - with the ingredients coming from Ayurveda, TCM, Jamu and other Southeast Asian botanicals.
  • Prebiotics and probiotics for benefits including, but not limited to, gut health, immunity, sleep, stress, anxiety, and other wellness areas
  • Proposals supporting health and wellness through nutrition, vitamins, minerals, botanicals, and other bioactive dietary constituents in the areas of
    • Immunity and inflammation and or nutrition
    • Cardiovascular and metabolic related issues (ie, diabetes/pre-diabetes/insulin resistance)
    • Aging (inclusive of brain health/cognition)
    • Real World Data research methods on dietary supplement product outcome and/or Wellness benefit (topics listed)
    • Womens/Mens/Adolescent Health
    • Digestive health/Microbiome
    • Mental health/resilience (including mood or motivation)
    • Health economic impact of dietary/nutrition supplementation
    • Population and sub-group level surveillance data on intakes of beneficial dietary constituents
Digital & Devices

Digital health can be broadly defined as the use of digital technology, data and the internet to improve either access, efficiency, the consumer/patient experience, or outcomes (or a combination of these) in healthcare.

We welcomes research proposals in the field of digital health. We have a broad scope of interest for such proposals and are keen to hear of any which may include studies that:
  • Assess the use of apps and other digital technologies to improve health outcomes or the patient/consumer experience in any of the therapy areas in which we have a publicly declared interest
  • Address the areas of resilience, pain, anxiety, smoking cessation (and other forms of addiction), health-related behaviour change, weight management, wellness, mental health, oral health, allergy, infectious diseases and cold & flu
  • Assess the utility of digital therapeutics or platforms in areas of interest, where the therapeutic/platform may be a standalone intervention or an adjunct to a conventional medicine/medical device
  • Investigate the potential health benefits of wearable technologies
  • Investigate innovative ways to collect real world evidence on healthcare interventions
  • Investigate innovative ways to monitor/assess the safety of healthcare interventions
  • Investigate consumer, patient, HCP, regulator or policymaker attitudes to, and acceptance of, digital health interventions
  • Investigate how digital health interventions may reduce the burden on healthcare systems

Submit Your Consumer Health Proposal
© 2001-2022 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.